1. Клинические рекомендации "Миопия" http://avo-portal.ru/doc/fkr/item/257-miopiya

2. Аветисов Э.С. Близорукость/Э.С. Аветисов. - М.: Медицина, 1999. - 287 с.

3. Morgan I, Rose K. How genetic is school myopia? Progress in Retinal and Eye Research 2005; 24: 1 - 38.

4. Friedman NJ, Kaiser PK. Essentials of Ophthalmology. Philadelphia, PA: Elsevier Inc; 2007: 253 - 254.

5. Wu PC, Chen YJ, Chen CH, Chen YH, Shin SJ, Yang HJ, Kuo HK. Assessment of macular retinal thickness and volume in normal eyes and highly myopic eyes with third-generation optical coherence tomography. Eye (Lond). 2008 Apr; 22 (4): 551 - 5. doi: 10.1038/sj.eye.6702789.

6. Shimada N, Ohno-Matsui K, Harino S, Yoshida T, Yasuzumi K, Kojima A, Kobayashi K, Futagami S, Tokoro T, Mochizuki M. Reduction of retinal blood flow in high myopia. Graefes Arch Clin Exp Ophthalmol. 2004 Apr; 242 (4): 284 - 8. doi: 10.1007/s00417-003-0836-0.

7. Shih YF, Fitzgerald ME, Norton TT, Gamlin PD, Hodos W, Reiner A. Reduction in choroidal blood flow occurs in chicks wearing goggles that induce eye growth toward myopia. Curr Eye Res. 1993 Mar; 12 (3): 219 - 27. doi: 10.3109/02713689308999467.

8. Sayanagi K, Ikuno Y, Uematsu S, Nishida K. Features of the choriocapillaris in myopic maculopathy identified by optical coherence tomography angiography. Br J Ophthalmol. 2017 Nov; 101 (11): 1524 - 1529. doi: 10.1136/bjophthalmol-2016-309628.

9. Steidl SM, Pruett RC. Macular complications associated with posterior staphyloma. Am J Ophthalmol 1997; 123: 181 - 7.

10. Ohsugi H., Ikuno Y., Shoujou T., et al. (2017). Axial length changes in highly myopic eyes and influence of myopic macular complications in Japanese adults. PLOS ONE. 12. e0180851. 10.1371/journal.pone.0180851.

11. Dimitrova G, Tamaki Y, Kato S, Nagahara M. Retrobulbar circulation in myopic patients with or without myopic choroidal neovascularisation. Br J Ophthalmol. 2002 Jul; 86 (7): 771 - 3. doi: 10.1136/bjo.86.7.771.

12. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009 Sep; 148 (3): 445 - 50. doi: 10.1016/j.ajo.2009.04.029.

13. Ikuno Y, Jo Y, Hamasaki T, Tano Y. Ocular risk factors for choroidal neovascularization in pathologic myopia. Invest Ophthalmol Vis Sci. 2010 Jul; 51 (7): 3721 - 5. doi: 10.1167/iovs.09-3493.

14. Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, A, Ruiz-Moreno JM. Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res. 2019; 69: 80 - 115. doi:10.1016/j.preteyeres.2018.10.005

15. Wakabayashi T, Ikuno Y, Oshima Y, Hamasaki T, Nishida K. Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization. J Ophthalmol. 2013; 2013: 257381. doi: 10.1155/2013/257381.

16. Chan WM, Ohji M, Lai TY, et al. Choroidal neovascularisation in pathological myopia: an update in management. Br J Ophthalmol. 2005; 89: 1522 - 1528.

17. Parolini B, Palmieri M, Finzi A, et al. The new myopic traction maculopathy staging system. Eur J Ophthalmol. 2021; 31 (3): 1299 - 1312.

18. High prevalence of myopia and high myopia in 5060 Chinese university students in Shanghai/J. Sun, J. Zhou, P. Zhao, J. Lian, H. Zhu, Y. Zhou, Y. Sun, Y. Wang, L. Zhao, Y. Wei, L. Wang, B. Cun, S. Ge, X. Fan//Invest. Ophthalmol. Vis. Sci. - 2012. - Vol. 53, N 12. - P. 7504 - 7509. DOI: 10.1167/iovs.11-8343.

19. Prevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in Seoul, South Korea/S.K. Jung, J.H. Lee, H. Kakizaki, D. Jee//Invest. Ophthalmol. Vis. Sci. - 2012. - Vol. 53, N 9. - P. 5579 - 5583. DOI: 10.1167/iovs.12-10106.

20. The age-specific prevalence of myopia in Asia: a meta-analysis/C.W. Pan, M. Dirani, C.Y. Cheng, T.Y. Wong, S.M. Saw//Optom Vis Sci. - 2015. - Vol. 92, N 3. - P. 258 - 66. DOI:10.1097/OPX.0000000000000516

21. Prevalence and associated factors of myopia in highschool students in Beijing/L.J. Wu, Q.S. You, J.L. Duan, Y.X. Luo, L.J. Liu, X. Li, Q. Gao, H.P. Zhu, Y. He, L. Xu, J.B. Jonas, W. Wang, X.H. Guo//PLoS One. - 2015. - Vol. 10, N 3: e0120764. URL: /https://journals.plos.org/plosone/article? id=10.1371/journal.pone.0120764. DOI: 10.1371/journal. pone.0120764. eCollection 2015

22. Increasing prevalence of myopia in Europe and the impact of education/K.M. Williams, G. Bertelsen, P. Cumberland, C. Wolfram, V.J. Verhoeven, E. Anastasopoulos, et al.//Ophthalmology. - 2015. - Vol. 122, N 7. - P. 1489 - 1497. DOI:10.1016/j.ophtha.2015.03.018

23. Prevalence of myopia in the United States/R.D. Sperduto, D. Seigel, J. Roberts, M. Rowland//Arch Ophthalmol. - 1983. - Vol. 101, N 3. - P. 405 - 407.

24. Vitale S., Sperduto R.D., Ferris F.L., 3rd. Increased prevalence of myopia in the United States between 1971 - 1972 and 1999 - 2004//Arch. Ophthalmol. - 2009. - Vol. 127, N 12. - P. 6321639. DOI: 10.1001/archophthalmol.2009.303

25. Prevalence of myopia and its risk factors in urban school children in Delhi: the North India Myopia Study (NIM Study)/R. Saxena, P. Vashist, R. Tandon, R.M. Pandey, A. Bhardawaj, V. Menon, K. Mani//PLoS One. - 2015. - Vol. 10, N 2.-:e0117349. URL:/https://www.researchgate.net/publication/272836803_Prevalence_of_Myopia_and_Its_Risk_Factors_in_Urban DOI: 10.1371/journal.pone.0117349. eCollection 2015

26. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050/B.A. Holden, T.R. Fricke, D.A. Wilson, M. Jong, K.S. Naidoo, P. Sankaridurg, T.Y. Wong, T.J. Naduvilath, S. Resnikoff//Ophthalmology. - 2016. - Vol. 123, N 5. - P. 1036 - 1042. DOI: 10.1016/j.ophtha.2016.01.006. Epub 2016 Feb 11.

27. Wright KW, Spiegal P. Pediatric Ophthalmology and Strabismus. New York, NY: Springer; 2003: 644 - 653.

28. American Academy of Ophthalmology. www.aao.org. [May 2010]???

29. Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol. 2014 Jan; 157 (1): 9 - 25. e12. doi: 10.1016/j.ajo.2013.08.010.

30. Нероев В.В. Инвалидность по зрению в Российской Федерации//Доклад на офтальмологическом конгрессе "Белые ночи-2017". СПб., 2017. [Электронный ресурс]. URL: http://avo-portal.ru/events/reports/item/266-invalidnost-po-zreniyu-v-rossiyskoy-federatsii (дата обращения: 24.03.2021).

31. Комплексный подход к профилактике и лечению прогрессирующей миопии у школьников/Е.П. Тарутта, Е.Н. Иомдина, Н.А. Тарасова, Г.А. Маркосян, М.В. Максимова//РМЖ. Клиническая офтальмология. - 2018. - N 2.- С. 70 - 76.

32. Flitcroft DI, He M, Jonas JB, et al. IMI - defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019; 60 (3): M20 - m30.

33. K. Ohno-Matsui (ed.), Atlas of Pathologic Myopia, https://doi.org/10.1007/978-981-15-4261-9_1

34. Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol. 2015; 159 (5): 877 - 83. e7

35. World Health Organization - Brien Holden Vision Institute. The impact of myopia. In: The Impact of Myopia and High Myopia. Report of the Joint World Health Organization - Brien Holden Vision Institute Global Scientific Meeting on Myopia. Available at: https://www.visionuk.org.uk/download/WHO_Report_Myopia_2016.pdf.

36. Fang Y, Du R, Nagaoka N, Yokoi T, Shinohara K, Xu X, Takahashi H, Onishi Y, Yoshida T, Ohno-Matsui K. OCT-Based Diagnostic Criteria for Different Stages of Myopic Maculopathy. Ophthalmology. 2019 Jul; 126 (7): 1018 - 1032. doi: 10.1016/j.ophtha.2019.01.012.

37. Ohno-Matsui K. Proposed classification of posterior staphylomas based on analyses of eye shape by three-dimensional magnetic resonance imaging and wide-field fundus imaging. Ophthalmology. 2014; 121 (9): 1798 - 809. https://doi.org/10.1016/j.ophtha.2014.03.035. [Published Online First: 2014/05/13]

38. Curtin BJ. The posterior staphyloma of pathologic myopia. Trans Am Ophthalmol Soc. 1977; 75: 67 - 86.

39. K. Ohno-Matsui (ed.), Atlas of Pathologic Myopia, https://doi.org/10.1007/978-981-15-4261-9_18

40. Bayer E.N. Peripheral retinal lesions to rhegmatogenous retinal detachment//Retina-Vitreous - Macula. - Philadelphia: Saunder's Company, 1999. - P. 1219 - 1248

41. Tideman JWL, Snabel MCC, Tedja MS, et al. Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia. JAMA Ophthalmol. 2016; 134 (12): 1355 - 1363. doi:10.1001/jamaophthalmol.2016.4009

42. When You Have Low Myopia And High Axial Length. https://www.myopiaprofile.com/low-myopia-and-high-axial-length/

43. Mutti DO, Mitchell GL, Sinnott LT, et al. Corneal and crystalline lens dimensions before and after myopia onset. Optom Vis Sci. 2012; 89 (3): 251 - 262.)

44. Blanco FG, Fernandez JC, Sanz MA. Axial length, corneal radius, and age of myopia onset. Optom Vis Sci. 2008 Feb 1; 85 (2): 89 - 96.

45. Kearney S, Strang NC, Cagnolati B, Gray LS. Change in body height, axial length and refractive status over a four-year period in caucasian children and young adults. Journal of Optometry. 2020 Jan 25.

46. Du R, Xie S, Igarashi-Yokoi T, et al. Continued Increase of Axial Length and Its Risk Factors in Adults With High Myopia. JAMA Ophthalmol. 2021; 139 (10): 1096 - 1103. doi: 10.1001/jamaophthalmol.2021.3303

47. Curtin BJ, Karlin DB Axial length measurements and fundus changes of the myopic eye. Part 1. The posterior fundus. Trans Am Opthalmol Soc. 1970; 68: 312 - 334.

48. Ohno-Matsui K. Posterior Staphyloma in Pathologic Myopia. Retinal Physician. 2017; 14: 38 - 40, 42.

49. Gaucher D, Erginay A, Lecleire-Collet A, et al. Dome-shaped macula in eyes with myopic posterior staphyloma. Am J Ophthalmol. - 2008; 145 (5): 909 - 914. doi: 10.1016/j.ajo.2008.01.012.

50. Hayashi K, Ohno-Matsui K, Shimada N, et al. Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology. 2010; 117 (8): 1595 - 1611. e16114. doi: 10.1016/j.ophtha.2009.11.003

51. Fang Y, Yokoi T, Nagaoka N, et al. Progression of Myopic Maculopathy during 18-Year Follow-up. Ophthalmology. 2018; 125 (6): 863 - 877. doi: 10.1016/j.ophtha.2017.12.005

52. Yu SY., Kim K. (2020) Myopic Choroidal Neovascularization. In: Chhablani J. (eds) Choroidal Neovascularization. Springer, Singapore. https://doi.org/10.1007/978-981-15-2213-0_9

53. Liang IC, Shimada N, Tanaka Y, et al. Comparison of Clinical Features in Highly Myopic Eyes with and without a Dome-Shaped Macula. Ophthalmology. 2015; 122 (8): 1591 - 1600. doi: 10.1016/j.ophtha.2015.04.012

54. Ohno-Matsui K, Yoshida T. Myopic choroidal neovascularization: natural course and treatment. Curr Opin Ophthalmol. 2004; 15 (3): 197 - 202. doi: 10.1097/01.icu.0000120709.35941.e9

55. Yoshida T, Ohno-Matsui K, Yasuzumi K, et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology. 2003; 110 (7): 1297 - 1305. doi: 10.1016/S0161-6420(03)00461-5

56. Kojima A, Ohno-Matsui K, Teramukai S, et al. Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol. 2004; 242 (2): 114 - 119. doi: 10.1007/s00417-003-0803-9

57. Ohno-Matsui K, Yoshida T, Futagami S, et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol. 2003; 87 (5): 570 - 573. doi: 10.1136/bjo.87.5.570

58. Cicinelli MV, La Franca L, De Felice E, Rabiolo A, Marchese A, Battaglia Parodi M, Introini U, Bandello F. Long-term incidence and risk factors of macular fibrosis, macular atrophy, and macular hole in eyes with myopic neovascularization. Ophthalmol Retina. 2022 Jun 27: S2468 - 6530(22)00316-5. doi: 10.1016/j.oret.2022.06.009.

59. Takano M, Kishi S. Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma. Am J Ophthalmol. 1999; 128 (4): 472 - 6.

60. Panozzo G, Mercanti A. Optical coherence tomography findings in myopic traction maculopathy. Arch Ophthalmol. 2004; 122 (10): 1455 - 60.

61. Ohno-Matsui, K. (2021). Myopic Macular Retinoschisis. In: Spaide, R.F., Ohno-Matsui, K., Yannuzzi, L.A. (eds) Pathologic Myopia. Springer, Cham. https://doi.org/10.1007/978-3-030-74334-5_20

62. ZK, Eltutar K, Karini B, Erkul , , Sultan P. Optic nerve head topography and retinal structural changes in eyes with macrodisks: a comparative study with spectral domain optical coherence tomography. Clin Ophthalmol. 2016 Sep 12; 10: 1737 - 42. doi: 10.2147/OPTH.S102789.

63. Wang YX, Panda-Jonas S, Jonas JB. Optic nerve head anatomy in myopia and glaucoma, including parapapillary zones alpha, beta, gamma and delta: Histology and clinical features. Prog Retin Eye Res. 2021 Jul; 83: 100933. doi: 10.1016/j.preteyeres.2020.100933.

64. Jonas JB, Weber P, Nagaoka N, Ohno-Matsui K. Glaucoma in high myopia and parapapillary delta zone. PLoS One. 2017 Apr 5; 12 (4): e0175120. doi: 10.1371/journal.pone.0175120.

65. Higginbotham J. What is High Myopia? And why does it matter? https://www.myopiafocus.org/high-myopia

66. Peterson J., Dawoud S.A., Mortensen Z., Binkley E. Pathologic Myopia. EyeRounds.org. 2021; February 24. Available at: https://EyeRounds.org/cases/310-pathologic-myopia.htm.

67. О классификационных подходах, терминологии и современных принципах лечения патологических изменений глаз, ассоциированных с близорукостью высокой степени. Часть 3. Подходы к мониторингу и лечению пациентов/В.В. Нероев, О.В. Зайцева, Е.П. Тарутта и др.//Российский офтальмологический журнал. - 2023. - N 16 (1 Приложение). - С. 23 - 39. DOI: 10.21516/2072-0076-2023-16-1-supplement-23-39

68. Motlagh M., Ramirez D.A., Binkley EM. Pathologic Myopia. EyeRounds.org. February 24, 2021. Available from https://EyeRounds.org/cases/310-pathologic-myopia.htm

69. Lauer A.K.,, Sundy M. Pathologic Myopia (Myopic Degeneration) https://eyewiki.org/Pathologic_Myopia_(Myopic_Degeneration)

70. Пантелеева О.А., Тарутта Е.П., Маркосян Г.А. Наследственные факторы в развитии миопии//Российский офтальмологический журнал. - 2009. - N 3. - С. 48 - 50.

71. Предикторы миопии как отправная точка для начала активных мер по предупреждению ее развития/Е.П. Тарутта, О.В. Проскурина, Н.А. Тарасова, Р.А. Ибатулин Р.А., А.С. Ковычев//Российский офтальмологический журнал. - 2018. - Т. 11, N 3. - С. 107 - 112. DOI: 10.21516/2072-0076-2018-11-3-107-112

72. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysisand systematic review/S. Xiong, P. Sankaridurg, T. Naduvilath, J. Zang, H. Zou, J. Zhu, M. Lv, X. He, X. Xu//Acta Ophthalmol. - 2017. - Vol. 95, N 6. - P. 551 - 566. DOI: 10.1111/aos.13403

73. The association between time spent outdoors and myopia in children and adolescents: A systematic review and meta-analysis/J.C. Sherwin, M.H. Reacher, R.H. Keogh, A.P. Khawaja, D.A. MacKey, P.J. Foster//Ophthalmology. - 2012. - Vol. 119, N 10. - P. 2141 - 2151. DOI: 10.1016/j.ophtha.2012.04.020. Epub 2012 Jul 17

74. Опросник Macular disease Treatment Satisfaction Questionnaire (MacTSQ) https://healthpsychologyresearch.com/guidelines/mactsq-macular-disease-treatment-satisfaction-questionnaire/

75. Нероев В.В., Астахов Ю.С., Коротких С.А., Бобыкин Е.В., Зайцева О.В., Лисочкина А.Б., Бровкина А.Ф., Будзинская М.В., Гацу М.В., Григорьева Н.Н., Измайлов А.С., Карлова Е.В., Ковалевская М.А., Нечипоренко П.А., Панова И.Е., Рябцева А.А., Симонова С.В., Тульцева С.Н., Фурсова А.Ж., Шадричев Ф.Е., Шишкин М.М., Харлампиди М.П. Протокол выполнения интравитреального введения лекарственных препаратов. Консенсус Экспертного совета по заболеваниям сетчатки и зрительного нерва Общероссийской общественной организации "Ассоциация врачей-офтальмологов". Вестник офтальмологии. 2020; 136 (6): 251 - 263. https://doi.org/10.17116/oftalma2020136062251.

76. СанПиН 2.1.3.2630-10 "Санитарно-эпидемиологические требования к организациям, осуществляющим медицинскую деятельность".

77. Приказ Министерства здравоохранения и социального развития РФ от 29 декабря 2008 г. N 786н "О порядке формирования и утверждении государственного задания на оказание в 2009 году высокотехнологичной медицинской помощи гражданам Российской Федерации за счет ассигнований федерального бюджета" (с изменениями и дополнениями).

78. Управление плановой госпитализацией в многопрофильной больнице. Методические рекомендации N 2001/144: (утв. Минздравом РФ 09.11.2001).

79. Розенблюм Ю.З. Функционально-возрастной подход к компенсации аметропии//Вестн. офтальмол. - 2004. - N 1. - С. 51 - 56

80. Тарутта Е.П. Прогрессирующая и осложненная близорукость. В кн.: Педиатрия. Национальное руководство. Т. 2. М.: Гоэтар-Медиа, 2009. - С. 816 - 22

81. Проскурина О.В. Статическая и динамическая ретиноскопия (скиаскопия)//Вестник оптометрии. - 2012. - N 5. - С. 44 - 46

82. Розенблюм Ю.З., Проскурина О.В. Применение автоматических рефрактометров в практике врача офтальмолога и оптометриста//Вестн. оптометрии. - 2001. - N 5. - С. 9 - 17.

83. Розенблюм Ю.З. Оптмометрия/Ю.З. Розенблюм. - С-Пб: Гиппократ, 1996. - 247 с.

84. Проскурина О.В. Циклоплегическая эффективность препаратов циклопентолата и тропикамида в сравнении с атропинизацией//Вестн. офтальмол. - 2002. - N 6. - С. 45 - 48

85. Comparison of cyclopentolate versus tropicamide cycloplegia: A systematic review and meta-analysis./N. Yazdani, R. Sadeghi, H. Momeni-Moghaddam, L. Zarifmahmoudi, A. Ehsaei//J. Optom. - 2017. - Vol. 11, N 3. - P. 135 - 143. DOI: 10.1016/j.optom.2017.09.001. Epub 2017 Nov 11

86. American Academy of Ophthalmology Preferred Practice Patterns Committee. Preferred Practice Guidelines. Comprehensive Adult Medical Eye Evaluation. San Francisco, CA: AAO (2005). Available at: http://www.aao.org/ppp.

87. Офтальмология: национальное руководство/ред. С.Э. Аветисов, Е.А. Егоров, Л.К. Мошетова, В.В. Нероев, Х.П. Тахчиди. - 2ое изд - М.: ГЭОТАР-Медиа, 2018. - 904 с. - (Серия "Национальное руководство")

88. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia./D.O. Mutti, J.R. Hayes, G.L. Mitchell, L.A. Jones, M.L. Moeschberger, S.A. Cotter, R.N. Kleinstein, R.E. Manny, J.D. Twelker//Invest. Ophthalmol. Vis. Sci. - 2007. - Vol. 48, N 6. - P. 2510 - 2519.

89. Акустическая плотность склеры как фактор прогноза развития ПВХРД при миопии: результаты 10-летнего динамического наблюдения/Е.П. Тарутта, М.В. Максимова, Г.В. Кружкова, Н.В. Ходжабекян, Г.А. Маркосян//Вестник офтальмологии. - 2013. - N 1. - С. 16 - 20.

90. Акустические исследования склеры при прогрессирующей близорукости у детей и подростков/Э.С. Аветисов, Ф.Е. Фридман, Е.П. Тарутта, Г.В. Кружкова, Н.В. Ходжабекян//Вестник офтальмологии. - 1996. - Т. 112, N 2. - С. 41 - 43.

91. Динамика периферической рефракции и формы глаза на фоне ношения ортокератологических линз у детей с прогрессирующей миопией/Е.П. Тарутта, Е.Н. Иомдина, Р.Р. Толорая, Г.В. Кружкова//Российский офтальмологический журнал. - 2016. - Т. 9, N 1. - С. 62 - 66. DOI: 10.21516/2072-0076-2016-9-1-62-66.

92. Clinical management guidelines report/K.L. Gifford, K.Richdale, P. Kang, T.A. Aller, C.S. Lam, Y.M. Liu, L. Michaud, J. Mulder, J.B. Orr, K.A. Rose, K.J.S aunders, D. Seidel, J.W.L. Tideman, P. Sankaridurg//Invest. Ophthalmol. Vis. Sci. - 2019. - Vol. 60, N 3. - P. 184 - 203. DOI: 10.1167/iovs.18-25977.

93. Ультразвуковые исследования в офтальмологии: Руководство для врачей/под редакцией В.В. Нероева и Т.Н. Киселевой. 1-е издание. - М: Издательство ИКАР, 2019. - 322 с., илл.

94. Paralejas A., Garcia M. Degenerative Myopia with Macular Thinning and Retinal Window Defect: A Stage Before Retinal Detachment. 2020. 10.2991/ahsr.k.200523.068.

95. Verkicharla, P.K., Ohno-Matsui K., Saw S.M. Current and predicted demographics of high myopia and an update of its associated pathological changes. Ophthalmic and Physiological Optics, 2015. 35 (5): p. 465 - 475.

96. Li J, Zhao X, Chen S, et al. Patterns of Fundus Autofluorescence in Eyes with Myopic Atrophy Maculopathy: A Consecutive Case Series Study. Curr Eye Res. 2021; 46 (7): 1056 - 1060. doi: 10.1080/02713683.2020.1857780.

97. Yana, M., Onishi, Y. (2020). Myopic Macular Neovascularization; Treatment Outcome (Including MP3). In: Ohno-Matsui, K. (eds) Atlas of Pathologic Myopia. Springer, Singapore. https://doi.org/10.1007/978-981-15-4261-9_12

98. Chhablani J, Deepa MJ, Tyagi M, Narayanan R, Kozak I. Fluorescein angiography and optical coherence tomography in myopic choroidal neovascularization. Eye (Lond). 2015; 29 (4): 519 - 524. doi: 10.1038/eye.2014.345

99. Widefield Angiography of the Peripheral Retina. A review of modalities for widefield angiography and their application for various pathologies/Corvi F., Pace L., Pellegrini M., et al.//Retinal Physician, Volume: 14, Issue: April 2017, P: 30 - 37.

100. Wen F, Wu D, Wu L. [The fluorescein angiography and indocyanine green angiography of high myopia with macular hemorrhage]. Zhonghua Yan Ke Za Zhi. 1998 Jul; 34 (4): 267 - 9, 18. Chinese.

101. Querques L, C, Corvi F, et al. Optical coherence tomography angiography of myopic choroidal neovascularisation. Br J Ophthalmol. 2017; 101 (5): 609 - 615. doi: 10.1136/bjophthalmol-2016-309162

102. Patel A, Patel D, Prajapati V, Patil MS, Singhal D. A Study on the Association Between Myopia and Elevated Intraocular Pressure Conducted at a Tertiary Care Teaching Hospital in Gujarat, India. Cureus. 2022 Aug 18; 14 (8): e28128. doi: 10.7759/cureus.28128.

103. Kader MA. Electrophysiological study of myopia. Saudi J Ophthalmol. 2012; 26 (1): 91 - 99. doi: 10.1016/j.sjopt.2011.08.002

104. Spectacle lenses designed to reduce progression of myopia: 12-month results/P. Sankaridurg, L. Donovan, S. Varnas, A. Ho, X. Chen, A. Martinez, S. Fisher, Z. Lin, E.L. Smith 3rd, J. Ge, B. Holden//Optom Vis Sci. - 2010. - Vol. 87, N 9. - P. 631 - 641. DOI: 10.1097/OPX.0b013e3181ea19c7.

105. Влияние занятий бадминтоном на рефракцию, аккомодацию и гемодинамику глаз с миопией/Е.П. Тарутта, Н.А. Тарасова, С.В. Милаш, Г.А. Маркосян, К.А. Рамазанова К.А.//Современная оптометрия. - 2019. - N 1. - С. 22 - 29.

106. Аветисов Э.С., Ливадо Е.И., Курпан Ю.И. Занятия физической культурой при близорукости. - М.: Физкультура и спорт, 1983. - 103 с.

107. Хурай А.Р. Допуск к занятиям физической культурой и спортом при заболеваниях органа зрения. Методические рекомендации. - М.: ФГУ "ЦСМ ФМБА России", 2010. - 60 с.

108. Parodi MB, Iacono P, Papayannis A, Sheth S, Bandello F. Laser Photocoagulation, Photodynamic Therapy, and Intravitreal Bevacizumab for the Treatment of Juxtafoveal Choroidal Neovascularization Secondary to Pathologic Myopia. Arch Ophthalmol. 2010; 128 (4): 437 - 442. doi: 10.1001/archophthalmol.2009.408

109. Chen Y, Sharma T, Li X, et al. RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION: BRILLIANCE, a 12-Month, Randomized, Double-Masked Study. Retina. 2019; 39 (10): 1985 - 1994. doi: 10.1097/IAE.0000000000002292

110. Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, Lim JI, Menchini U, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld P, Schachat AP, Schmidt-Erfurth U, Sickenberg M, Singerman LJ, Slakter JS, Strong HA, Virgili G, Williams GA. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology. 2003 Apr; 110 (4): 667 - 73. doi: 10.1016/s0161-6420(02)01998-x.

111. Tan N.W., Ohno-Matsui K., Koh H.J., Nagai Y., Pedros M., Freitas R.L., Macfadden W., Lai T.Y. Long-term outcomes of ranibizumab treatment of myopic choroidal neovascularization in east-asian patients from the RADIANCE study. Retina. 2018; 38 (11): 2228 - 2238. DOI: 10.1097/IAE.0000000000001858.

112. Tufail A., Narendran N., Patel P.J., Sivaprasad S., Amoaku W., Browning A.C., Osoba O., Gale R., George S., Lotery A.J., Majid M., McKibbin M., Menon G., Andrews C., Brittain C., Osborne A., Yang Y. Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study. Ophthalmology. 2013; 120 (9): 1944 - 1945. e1. DOI: 10.1016/j.ophtha.2013.06.010.

113. Wolf S. et al. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia//Ophthalmology. - 2014. - Т. 121. - N. 3. - С. 682 - 692. e2.

114. Коротких С.А., Бобыкин Е.В. Миопическая макулопатия: метод. рекомендации. - Екатеринбург: Изд-во УГМУ, 2017. - 64 с.

115. Ikuno Y., Ohno-Matsui K., Wong T.Y., Korobelnik J.F., Vitti R., Li T., Stemper B., Asmus F., Zeitz O., Ishibashi T. Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology. 2015; 122 (6): 1220 - 1227. DOI: 10.1016/j.ophtha.2015.01.025.

116. Коротких С.А. Режимы применения анти-VEGF терапии в офтальмологии (практическое пособие с клиническими примерами)/С.А. Коротких, Е.В. Бобыкин. - Екатеринбург: УГМУ, 2020. - 92 с.

117. Инструкция по медицинскому применению лекарственного препарата "Луцентис". Регистрационный номер: ЛСР-004567/08 (версия от 15.06.2020). Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=0264cec1-448c-4ceb-8ce4-b0ae7702f557&t=. Ссылка активна на 23.09.2022.

118. Инструкция по медицинскому применению лекарственного препарата "Эйлеа". Регистрационный номер: ЛП-003544 (версия от 17.07.2020.). Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=ee3a3a12-b52a-47f6-b35b-57c1d75c3d38&t=. Ссылка активна на 31.08.2021.

119. Flaxel C., Adelman R., Bailey S., Fawzi A., Lim J., Vemulakonda G., Ying G.: Idiopathic Epiretinal Membrane and Vitreomacular Traction Preferred Practice Pattern. Ophthalmology. 2020 Feb; 127 (2): P 145 - P 183. doi: 10.1016/j.ophtha.2019.09.022.

120. Flaxel C., Adelman R., Bailey S., Fawzi A., Lim J., Vemulakonda G., Ying G. Idiopathic Macular Hole Preferred Practice Pattern. Ophthalmology. 2020 Feb; 127 (2): P 184 - P 222. doi: 10.1016/j.ophtha.2019.09.026.

121. Parolini B., Palmieri M., Finzi A., Besozzi G., Frisina R.: Myopic Traction Maculopathy: A New Perspective on Classification and Management. Asia Pac J Ophthalmol. 2021 Jan 20; 10 (1): 49 - 59. doi: 10.1097/APO.0000000000000347.

122. Brown G., Karth P., Hunter A.: Novel Postoperative Dropless Protocol for Micro-Incision Vitrectomy Surgery. Ophthalmic Surg Lasers Imaging Retina. 2021 Nov; 52 (11): 587 - 591. doi: 10.3928/23258160-20211014-01.

123. Royal College of Anaesthetists and Royal College of Ophthalmologists. Local Anaesthesia in Ophthalmic Surgery 2012.

124. National Institute for Health and Care Excellence. Eye conditions. 2019.

125. The Royal College of Ophthalmologists. Managing an outbreak of postoperative endophthalmitis. 2016.

126. Gui J., Ai L., Huang T: Vitrectomy with or without internal limiting membrane peeling for myopic foveoschisis. BMC Ophthalmol. 2020 Mar 4; 20 (1): 83. doi: 10.1186/s12886-020-01354-8.

127. Parolini B., Palmieri M., Finzi A., Frisina R.: Proposal for the management of myopic traction maculopathy based on the new MTM staging system. Eur J Ophthalmol. 2021 Nov; 31 (6): 3265 - 3276. doi: 10.1177/1120672120980943.

128. Fang D., Su J., Chen L., Zhang S.: The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction Maculopathy. Front Med (Lausanne). 2022 Jan 7; 8: 802626. doi: 10.3389/fmed.2021.802626.

129. Li S., Li T., Wang X., Cai X., Lu B., Chen Y., Liu C., Wu Q.: Natural course of myopic traction maculopathy and factors influencing progression and visual acuity. BMC Ophthalmol. 2021 Sep 25; 21 (1): 347. doi: 10.1186/s12886-021-02087-y.

130. Wu J., Xu Q., Luan J.: Vitrectomy with fovea-sparing ILM peeling versus total ILM peeling for myopic traction maculopathy: A meta-analysis/Eur J Ophthalmol. 2021 Sep; 31 (5): 2596 - 2605. doi: 10.1177/1120672120970111.

131. Pollack J., Sabherwal N.: Small gauge vitrectomy: operative techniques. Curr Opin Ophthalmol. 2019 May; 30 (3): 159 - 164. doi: 10.1097/ICU.0000000000000568.

132. Bopp S., Kellner U.: Pars plana vitrectomy. Klin Monbl Augenheilkd. 2019 May; 236 (5): 705 - 722. doi: 10.1055/a-0849-0148.

133. Diaz J., Arroyo J.: Modern Clinical Applications of Endoscopic Pars Plana Vitrectomy in Vitreoretinal Surgery. Int Ophthalmol Clin/2020 Winter; 60 (1): 25 - 33. doi: 10.1097/IIO.0000000000000295.

134. Mahmoudzadeh R, Patel S.N., Wakabayashi T. How to Manage Pathologic Myopia https://www.reviewofophthalmology.com/article/how-to-manage-pathologic-myopia

135. Parolini B. Manage Myopic Traction Maculopathy With Ease https://retinatoday.com/articles/2022-july-aug/manage-myopic-traction-maculopathy-with-ease

136. Gifford K., Richdale K., Kang P., Aller T., Lam C., Liu Y., Michaud L., Mulder J., Orr J., Rose K., Saunders K., Seidel S., Tideman J., Sankaridurg P.: IMI - Clinical Management Guidelines Report. Invest Ophthalmol Vis Sci. 2019 Feb 28; 60 (3): M 184 - M 203. doi: 10.1167/iovs.18-25977.

137. The Clinical Council for Eye Health Commissioning (CCEHC). Strategy 2016 - 2018 - Commissioning for the needs of the patients; enhancing eye health services.

138. Feng J., Yu J., Chen Q., Zhou H., Chen C., Wang W., Xu X., Fan Y.: Long-term surgical outcomes and prognostic factors of foveal detachment in pathologic myopia: based on the ATN classification. BMC Ophthalmol. 2022 Apr 18; 22 (1): 175. doi: 10.1186/s12886-022-02391-1.

139. The Royal Australian and New Zealand College of Ophthalmologists. RANZCO Laser Safety Protocol. 2015.

140. Херш П.С., Загельбаум Б.М., Кремерс С.Л. Офтальмохирургия. Пер. с англ./М.: Мед. лит., Витебск - 2016. - 400 с.

141. Omari A, Mahmoud TH. Vitrectomy. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551668/

142. Клинические рекомендации "Регматогенная отслойка сетчатки" http://avo-portal.ru/doc/fkr/item/247-regmatogennaya-otsloyka-setchatki

143. Flaxel C., Adelman R., Bailey S., Fawzi A., Lim J., Vemulakonda G., Ying G.: Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern. Ophthalmology. 2020 Jan; 127 (1): P 146 - P 181. doi: 10.1016/j.ophtha.2019.09.027.

144. Технические средства реабилитации для слабовидящих и слабослышащих https://mszn27.ru/node/7332

145. Ohno-Matsui K, Ikuno Y, Lai TYY, Gemmy Cheung CM, et al. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog Retin Eye Res. 2018; 63: 92 - 106.

146. Wong TY, Ohno-Matsui K, Leveziel N, Holz FG, Lai TY, Yu HG, Lanzetta P, Chen Y, Tufail A. Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol. 2015; 99: 289 - 96.

147. Quiroz-Reyes M. A. et al. Timing of vitrectomy in myopic traction maculopathy: A long term follow up report of a hispanic population//American Journal of Medicine and Surgery. - 2020. - Т. 1. - С. 7 - 14.

148. Kong K, Xu S, Wang Y, et al.. Progression Patterns of Myopic Traction Maculopathy in the Fellow Eye After Pars Plana Vitrectomy of the Primary Eye. Invest Ophthalmol Vis Sci. 2021 Dec 1; 62 (15): 9. doi: 10.1167/iovs.62.15.9.

149. Forooghian F. et al. Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept./Canadian Journal of Ophthalmology - 2017. - Vol. 52. N 6. - P. 616 - 619.

150. "Патологичесая миопия (информация для пациентов)" http://avo-portal.ru/forpatients

151. "Интравитреальные инъекции (информация для пациентов)" http://avo-portal.ru/forpatients